Bioherent

About:

Bioherent is a provider of diagnostic test for drug allergies.

Website: https://bioherent.com/

Top Investors: Centre for the Development of Industrial Technology (CDTI), Bullnet Capital

Description:

Bioherent develops in vitro diagnostic systems for the detection of allergies to beta-lactam antibiotics. Bioherent is based on integrated photonic sensors, and the company provides medical diagnostic tests for the detection of drug allergies. It develops sensitive, low-cost, in-vitro medical diagnostic technology. They develop in vitro diagnostic systems for the detection of allergies to beta-lactam antibiotics.

Total Funding Amount:

1.37M EUR

Headquarters Location:

Alhaurín De La Torre, Andalucia, Spain

Founded Date:

2021-01-01

Founders:

Number of Employees:

11-50

Last Funding Date:

2022-02-21

IPO Status:

Private

Industries:

© 2025 bioDAO.ai